EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials

Sidsel J Juul, Sára Rossetti, Berthe M P Aleman, Flora E van Leeuwen, Marleen A E van der Kaaij, Francesco Giusti, Paul Meijnders, John M M Raemaekers, Hanneke C Kluin-Nelemans, Michele Spina, Daphne Krzisch, Camille Bigenwald und 5 weitere

Journal of Cancer Survivorship · 2024

DOI: 10.1007/s11764-024-01694-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Survivorship, 2024. Verfasst von Sidsel J Juul und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Copenhagen University Hospital-Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. sidsel.jacobsen.juul@regionh.dk. Hauptthemen laut MEDLINE: Hodgkin Disease, Cancer Survivors, Physicians. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Studies looking into the concordance between late effects reported by physicians vs. those reported by Hodgkin lymphoma (HL) survivors are missing.

Methods

A Life Situation Questionnaire focusing on late effects collected data from 1230 HL survivors (median follow-up 14.3 years). Twenty-six disease- and treatment-related late effects from various organ systems were matched with physician-recorded data. The concordance between physicians and survivors was systematically evaluated using percentage agreement and kappa statistics. Potential non-responder biases and associations with patient and disease characteristics were also investigated.

Results

Agreement levels (indicated by kappa statistics) varied from none to moderate agreement, with the highest Kappa values observed for myocardial infarction (kappa = 0.55, 95% CI 0.43–0.66) and pulmonary embolism (kappa = 0.55, 95% CI 0.35–0.75). HL survivors consistently reported a higher prevalence of late effects compared with physicians. Notably, the prevalence of subjective symptoms such as persistent fatigue and xerostomia was repeatedly underreported by physicians. A trend towards higher concordance was observed in survivors with higher clinical stage, higher education level, and treatment initiated at younger ages. Additionally, findings indicated that survivors who did not respond to the questionnaire experienced fewer late effects compared to those who did respond.

Conclusions

Substantial discrepancies were noted in the reported prevalence of late effects between survivors and physicians, especially for outcomes which are not easily quantified. Implications for Cancer Survivors It is therefore essential to integrate outcomes reported by both physicians and survivors to achieve a comprehensive assessment of the long-term consequences of HL treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseCancer SurvivorsPhysiciansHumansMaleFemaleMiddle AgedAdultSurveys and QuestionnairesAgedYoung AdultFollow-Up StudiesQuality of LifeAdolescent

Stichwörter der Autor:innen

ConcordanceHodgkin lymphomaLate effectsPatient-reported outcomesSurvivorship

Autor:innen und Institutionen

  • Department of Oncology, Copenhagen University Hospital-Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. sidsel.jacobsen.juul@regionh.dk.
  • Department of Haematology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.
  • Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Department of Internal Medicine, Amstelland Hospital, Amstelveen, The Netherlands.
  • EORTC Headquarters, Brussels, Belgium.

Förderung

  • National Hospital

Zitieren

APA

Juul, S. J., Rossetti, S., Aleman, B. M. P., van Leeuwen, F. E., van der Kaaij, M. A. E., Giusti, F., Meijnders, P., Raemaekers, J. M. M., Kluin-Nelemans, H. C., Spina, M., Krzisch, D., Bigenwald, C., Stamatoullas, A., André, M., Plattel, W. J., Hutchings, M., & Maraldo, M. V. (2024). Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials. Journal of Cancer Survivorship. https://doi.org/10.1007/s11764-024-01694-0

Vancouver

Juul SJ, Rossetti S, Aleman BMP, van Leeuwen FE, van der Kaaij MAE, Giusti F, et al. Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials. Journal of Cancer Survivorship. 2024. doi:10.1007/s11764-024-01694-0

BibTeX
@article{Juul2024,
  author = {Juul, Sidsel J and Rossetti, Sára and Aleman, Berthe M P and van Leeuwen, Flora E and van der Kaaij, Marleen A E and Giusti, Francesco and Meijnders, Paul and Raemaekers, John M M and Kluin-Nelemans, Hanneke C and Spina, Michele and Krzisch, Daphne and Bigenwald, Camille and Stamatoullas, Aspasia and André, Marc and Plattel, Wouter J and Hutchings, Martin and Maraldo, Maja V},
  title = {Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials},
  journal = {Journal of Cancer Survivorship},
  year = {2024},
  doi = {10.1007/s11764-024-01694-0}
}
Kostenlos starten →